Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.56 - $3.25 $33,851 - $196,459
-60,449 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.46 - $5.92 $85,657 - $206,134
34,820 Added 135.86%
60,449 $183,000
Q4 2021

Feb 14, 2022

BUY
$4.26 - $23.33 $70,588 - $386,578
16,570 Added 182.91%
25,629 $132,000
Q3 2021

Nov 15, 2021

BUY
$18.12 - $28.5 $164,149 - $258,181
9,059 New
9,059 $219,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $55.6M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.